Your Health, We Care
Elacestrant is indicated for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.
from FDA，2023.05
LuciusVersionofElacestrant:DosageandAdministration,Indications,PrecautionsIndicationsElacestrant is ···【more】
Recommended：152025-03-12
LuciusVersionofElacestrant:DosageandAdministration,Indications,PrecautionsIndicationsElacestrant is an estrogen receptor antagonist indicated for:The treatment of postmenopausal wo···【more】
Article source：Lucius LaosRelease date：2025-12-03Recommended：15
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
